Kuhn Brooks T, Bradley Laura A, Dempsey Timothy M, Puro Alana C, Adams Jason Y
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of California at Davis, Sacramento, CA 95818, USA.
Department of Internal Medicine, School of Medicine, University of California at Davis, Sacramento, CA 95818, USA.
J Cardiovasc Dev Dis. 2016 Dec 2;3(4):33. doi: 10.3390/jcdd3040033.
Mechanical ventilation (MV) is a life-saving intervention for respiratory failure, including decompensated congestive heart failure. MV can reduce ventricular preload and afterload, decrease extra-vascular lung water, and decrease the work of breathing in heart failure. The advantages of positive pressure ventilation must be balanced with potential harm from MV: volutrauma, hyperoxia-induced injury, and difficulty assessing readiness for liberation. In this review, we will focus on cardiac, pulmonary, and broader effects of MV on patients with decompensated HF, focusing on practical considerations for management and supporting evidence.
机械通气(MV)是治疗呼吸衰竭(包括失代偿性充血性心力衰竭)的一种挽救生命的干预措施。MV可降低心室前负荷和后负荷,减少血管外肺水,并降低心力衰竭患者的呼吸功。正压通气的益处必须与MV可能带来的危害相权衡:容积伤、高氧诱导的损伤以及评估撤机准备情况的困难。在本综述中,我们将重点关注MV对失代偿性心力衰竭患者的心脏、肺部及更广泛的影响,着重探讨管理方面的实际考虑因素及支持证据。